MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 197 filers reported holding MYRIAD GENETICS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,398,153 | +120.9% | 179,810 | +92.6% | 0.00% | 0.0% |
Q1 2024 | $1,990,670 | +11.4% | 93,371 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $1,787,121 | +19.3% | 93,371 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $1,497,671 | -25.4% | 93,371 | +8.1% | 0.00% | 0.0% |
Q2 2023 | $2,007,235 | 0.0% | 86,407 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,007,235 | +91.6% | 86,407 | +19.7% | 0.00% | 0.0% |
Q4 2022 | $1,047,795 | -99.9% | 72,212 | -3.4% | 0.00% | 0.0% |
Q3 2022 | $1,426,383,000 | +2.1% | 74,758 | -2.8% | 0.00% | 0.0% |
Q2 2022 | $1,396,908,000 | -48.4% | 76,880 | -28.4% | 0.00% | 0.0% |
Q1 2022 | $2,707,160,000 | -8.9% | 107,427 | -0.2% | 0.00% | 0.0% |
Q4 2021 | $2,971,305,000 | -17.6% | 107,656 | -3.6% | 0.00% | 0.0% |
Q3 2021 | $3,606,051,000 | +18.1% | 111,677 | +11.8% | 0.00% | 0.0% |
Q2 2021 | $3,054,636,000 | +24.1% | 99,890 | +23.6% | 0.00% | 0.0% |
Q1 2021 | $2,460,604,000 | +61.7% | 80,808 | +5.0% | 0.00% | 0.0% |
Q4 2020 | $1,521,687,000 | +46.2% | 76,950 | -3.6% | 0.00% | 0.0% |
Q3 2020 | $1,041,035,000 | +15.0% | 79,834 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $905,317,000 | -32.5% | 79,834 | -14.9% | 0.00% | 0.0% |
Q1 2020 | $1,341,949,000 | -49.3% | 93,777 | -3.5% | 0.00% | -50.0% |
Q4 2019 | $2,645,096,000 | -3.3% | 97,139 | +1.7% | 0.00% | 0.0% |
Q3 2019 | $2,734,623,000 | +16.5% | 95,516 | +13.0% | 0.00% | 0.0% |
Q2 2019 | $2,347,187,000 | -3.0% | 84,492 | +15.9% | 0.00% | 0.0% |
Q1 2019 | $2,420,811,000 | +45.8% | 72,916 | +27.7% | 0.00% | +100.0% |
Q4 2018 | $1,659,984,000 | -25.6% | 57,103 | +17.8% | 0.00% | -50.0% |
Q3 2018 | $2,230,402,000 | +36.6% | 48,487 | +11.0% | 0.00% | +100.0% |
Q2 2018 | $1,632,211,000 | +6.4% | 43,677 | -15.9% | 0.00% | 0.0% |
Q1 2018 | $1,534,472,000 | -12.3% | 51,928 | +1.9% | 0.00% | 0.0% |
Q4 2017 | $1,750,016,000 | +0.1% | 50,954 | +5.4% | 0.00% | -50.0% |
Q3 2017 | $1,748,905,000 | +50.7% | 48,339 | +7.6% | 0.00% | +100.0% |
Q2 2017 | $1,160,448,000 | +75.9% | 44,909 | +30.7% | 0.00% | 0.0% |
Q1 2017 | $659,788,000 | +166934.9% | 34,364 | +45.0% | 0.00% | – |
Q4 2016 | $395,000 | -56.7% | 23,697 | -46.5% | 0.00% | -100.0% |
Q3 2016 | $912,000 | -35.4% | 44,297 | -4.0% | 0.00% | -50.0% |
Q2 2016 | $1,411,000 | -62.0% | 46,123 | -53.6% | 0.00% | -50.0% |
Q1 2016 | $3,718,000 | -16.8% | 99,320 | -4.1% | 0.00% | -20.0% |
Q4 2015 | $4,469,000 | +5.9% | 103,535 | -8.1% | 0.01% | 0.0% |
Q3 2015 | $4,222,000 | +19.9% | 112,630 | +8.8% | 0.01% | +66.7% |
Q2 2015 | $3,520,000 | -22.6% | 103,551 | -19.4% | 0.00% | -25.0% |
Q1 2015 | $4,549,000 | +29.2% | 128,500 | +24.3% | 0.00% | +33.3% |
Q4 2014 | $3,522,000 | -14.9% | 103,400 | -3.7% | 0.00% | -25.0% |
Q3 2014 | $4,140,000 | -3.2% | 107,342 | -2.4% | 0.00% | 0.0% |
Q2 2014 | $4,278,000 | -82.1% | 109,942 | -84.3% | 0.00% | -84.6% |
Q1 2014 | $23,925,000 | +59.9% | 699,763 | -1.9% | 0.03% | +52.9% |
Q4 2013 | $14,967,000 | -1.9% | 713,404 | +9.9% | 0.02% | -10.5% |
Q3 2013 | $15,257,000 | +45.6% | 649,238 | +66.5% | 0.02% | +35.7% |
Q2 2013 | $10,480,000 | – | 390,038 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |